Crescita Therapeutics (TSE:CTX) Hits New 1-Year High – What’s Next?

Shares of Crescita Therapeutics Inc. (TSE:CTX) reached a new 52-week high on Tuesday . The stock traded as high as C$0.79 and last traded at C$0.79, with a volume of 4646 shares. The stock had previously closed at C$0.75.

Crescita Therapeutics Trading Up 5.3%

The company has a fifty day simple moving average of C$0.75 and a two-hundred day simple moving average of C$0.58. The company has a quick ratio of 2.29, a current ratio of 2.80 and a debt-to-equity ratio of 17.34. The stock has a market capitalization of C$14.71 million, a P/E ratio of -79.00 and a beta of -1.34.

Crescita Therapeutics (TSE:CTX) last posted its earnings results on Monday, May 11th. The company reported C($0.06) earnings per share for the quarter. The business had revenue of C$5.64 million for the quarter. Crescita Therapeutics had a negative return on equity of 2.07% and a negative net margin of 1.38%.

About Crescita Therapeutics

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The firm generates its revenue in the form of product sales and out-licensing revenue.